Latest News about Dea
Recent news which mentions Dea
3 No-Brainer Dividend Stocks to Buy in 2023
January 16, 2023
From Motley Fool
Here's the First Stock I'm Buying in 2023
January 09, 2023
From Motley Fool
3 Dividend Stocks I Plan to Buy in 2023
January 06, 2023
From Motley Fool
3 Top Income Stocks to Buy for 2023
January 05, 2023
From Motley Fool
"Motley Fool Money" 2023 Investing Preview
January 04, 2023
From Motley Fool
23 Top Dividend Stocks to Buy and Hold in 2023
January 03, 2023
From Motley Fool
Why a New Bull Market Is Likely in 2023 -- and 3 Stocks to Buy to Profit if It Comes
January 02, 2023
From Motley Fool
From Cannabis Killing 100% Cancer Cells To Snoop Dog Microwaving His Blunts: Benzinga's Most-Read Marijuana Stories In 2022
December 29, 2022
From Benzinga
Most Affordable Stocks In The Real Estate Sector: Uniti Group, CBL & Associates Properties And More
December 21, 2022
From Benzinga
These 3 NYSE-Traded REITs All Hit New 12-Month Lows
December 19, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
December 16, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
From Benzinga
Donald Trump And Viktor Bout Seem To Have A Few Things In Common Despite The Former Pres' Protests
December 12, 2022
Tickers
DEA
From Benzinga
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
December 06, 2022
From Benzinga
12 Top Stocks to Buy in December
December 03, 2022
From Motley Fool
DEA Legalizes Cocaine Derivative As Diagnostic Aid For Parkinson's, Ignoring Cannabis Experts Seeking Same
November 23, 2022
Tickers
DEA
From Benzinga
Exclusive: BioHarvest Partners With DEA-Licensed Cannabis Grower To Supply Marijuana Products To Research Institutions
November 16, 2022
From Benzinga
3 Safe Dividend Stocks to Beat Inflation
November 10, 2022
From Motley Fool
4 Analysts Have This to Say About Easterly Government Props
November 03, 2022
Tickers
DEA
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
November 03, 2022
From Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
October 27, 2022
From Benzinga
3 Top Dividend Stocks to Buy and Hold in 2023
October 25, 2022
From Motley Fool
3 High-Yield Dividend Stocks That Could Be Passive-Income Machines
October 22, 2022
From Motley Fool
3 Attractive REITs With A Dividend Yield Over 6%
October 13, 2022
From Benzinga
3 Ridiculously Cheap High-Yield Dividend Stocks
October 12, 2022
From Motley Fool
DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round
October 04, 2022
From Benzinga
DEA's Alarming Fentanyl Seizure, Nevada's Nearly $1B In Sales, Oregon Raids Yield Hefty Fines & More
October 04, 2022
From Benzinga
DEA Claims Doctors Requesting Psilocybin For Dying Patients Have Commercial Interests
September 29, 2022
Tickers
DEA
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.